January 2026
The global type 1 diabetes market size is estimated at USD 37.60 billion in 2025 and is projected to hit around USD 79.14 billion by 2035 with a CAGR of 7.73%.
February 2026
The global type 2 diabetes market size was valued at USD 40.09 billion in 2025 and is projected to hit around USD 79.25 billion by 2035 with a CAGR of 7.05%.
October 2025
The global Type 2 diabetes management market explores the growth of therapeutic, monitoring and digital solutions driven by rising global prevalence, obesity and lifestyle-related risks.
September 2025
The global GLP-1 analogues market size was evaluated at USD 49.90 billion in 2024 and is predicted to hit around USD 879.90 billion by 2034, growing at a CAGR of 33.24%.
February 2026
The global diabetes associated ophthalmic treatment market size was evaluated at USD 6.91 billion in 2025 and is predicted to hit around USD 12.65 billion by 2035, growing at a CAGR of 6.24%.
January 2026
The global diabetes care devices market size was evaluated at USD 68.57 billion in 2025 and is predicted to hit around USD 125.03 billion by 2035, growing at a CAGR of 6.19%.
July 2025
The global diabetes drug market size was calculated at USD 70.40 billion in 2024 and is projected to hit around USD 132.36 billion by 2034 with a CAGR of 6.5%.
May 2025
The digital diabetes management market size was recorded at USD 31.90 billion in 2024 and is projected to cross around USD 171.63 billion by 2034, at a CAGR of 18.33%
June 2026
The global prediabetes market size is calculated at USD 322.14 million in 2025 and is estimated to hit around USD 635.6 million by 2035 with a CAGR of 7.03%.
June 2026
The global hemoglobin A1c testing devices market size is estimated to hit around USD 4.72 billion by 2035 from USD 2.52 billion in 2025, with a CAGR of 6.48%.
June 2026
The global diabetes devices market size accounted for USD 35.26 billion in 2025 and is projected to hit around USD 73.43 billion by 2035, growing at a CAGR of 7.61%.
June 2026
The global 1,5-hexadiene market size is expected to increase from USD 185.00 million in 2025 to hit USD 317.00 million by 2035, growing at a CAGR of 5.80%.
February 2026
The global S1P receptor modulator drugs market size is estimated to hit around USD 6.96 billion by 2035 increasing from USD 3.16 billion in 2025, with a CAGR of 8.22%.
February 2026
The global obesity GLP-1 market size was evaluated at USD 8.21 billion in 2025 and is predicted to hit around USD 66.57 billion by 2035, growing at a CAGR of 23.28%.
January 2026
The pet diabetes care devices market size was estimated at USD 2.58 billion in 2025 and is projected to worth around USD 5.54 billion by 2035, with a CAGR of 6.87%.
November 2025
The global alpha-1 antitrypsin deficiency augmentation therapy market size is estimated to hit around USD 2.96 billion by 2034 from USD 1.73 billion in 2025, at a CAGR of 6.14%.
October 2025
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
August 2025
The global diabetes nutrition market size is estimated to hit around USD 25.22 billion by 2034 increasing from USD 12.64 billion in 2024, with a CAGR of 7.15%.
August 2025
The global triazine type UV absorber market size is estimated to hit around USD 2.90 billion by 2034 increasing from USD 1.28 billion in 2024, with a CAGR of 8.53%.
July 2025
The global mounjaro market size is estimated to hit around USD 78.51 billion by 2034 increasing from USD 14.18 billion in 2024, with a CAGR of 18.67%.
June 2025
The global tubeless insulin pump market size was evaluated at USD 2.45 billion in 2024 and is projected to reach around USD 13.65 billion by 2034, with a CAGR of 18.74%.
June 2025
The global coenzyme Q10 market size was evaluated at USD 733.09 million in 2024 and is predicted to surpass around USD 1,847.29 million by 2034, at a notable CAGR of 9.68%.
May 2025
The global PD-1 inhibitor drugs market size was estimated at USD 42.11 billion in 2024 and is expected to hit around USD 179.77 billion by 2034, growing at a CAGR of 15.62% from 2025 to 2034.
April 2025
The global K-12 furniture market size was estimated at USD 6.01 billion in 2024 and is expected to hit around USD 9.93 billion by 2034, growing at a CAGR of 5.15% from 2025 to 2034.
April 2025
The diabetes management technologies market is set to grow significantly by 2034, driven by innovations in glucose monitoring, insulin delivery, and digital health solutions.
April 2025
The Australia GLP-1 receptor agonist market size was valued at USD 499.12 million in 2024 and is expected to hit around USD 1,899.62 million by 2034, growing at a CAGR of 14.30% from 2025 to 2034.
March 2025
The global K 12 instructive toy market size is estimated to hit around USD 173.70 billion by 2034 increasing from USD 71.38 billion in 2024, with a CAGR of 9.30%.
July 2025
The global industrial films market size is estimated at USD 45.59 billion in 2024 and is projected to hit around USD 74.20 billion by 2034 with a CAGR of 4.99%.
June 2026
The global neuroendocrine tumor treatment market size is estimated to surpass around USD 5.16 billion by 2035 from USD 2.88 billion in 2025, at a solid CAGR of 6.00%.
June 2026
The global digital patient monitoring devices market size is expected to hit around USD 144.16 billion by 2035 from USD 16.20 billion in 2025 with a CAGR of 24.43%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com